Interventional Cardiovascular Surgery

Cardiac surgery is surgery on the heart or great vessels performed by cardiac surgeons. It is often used to treat complications of ischemic heart disease (for example, with coronary artery bypass grafting) or to treat valvular heart disease from various causes. Cardiac surgeons, interventional cardiologists and imaging specialists typically work together as the Heart Team, in particular in structural heart centres of excellence. In this section, you will find a selection of content in the field of interventional vardiovascular surgery.

View the Interventional CV Surgery editorial team

Read the editorial by F. Maisano and W. Wijns

Filtered By
TOPICS

117 results

Atrial functional tricuspid regurgitation: Importance of atrial fibrillation and right atrial remodeling and prognostic significance

18 Jul 2023

- When tricuspid regurgitation “begets” tricuspid regurgitation -

Edoardo Zancanaro

Reviewer

Edoardo Zancanaro
Atrial functional tricuspid regurgitation importance of atrial fibrillation and right atrial remodeling and prognostic significance. When tricuspid regurgitation “begets” tricuspid regurgitation

Percutaneous coronary intervention vs coronary artery bypass graft surgery for left main disease in patients with and without acute coronary syndromes: a pooled analysis of 4 randomized clinical trials

05 Jul 2023

This patient-level analysis of randomized trials comparing PCI vs CABG for the treatment of low-to-intermediate CAD involving the LM confirms the absence of long-term differences in mortality between revascularization techniques, regardless of the clinical presentation.

Giovanni Occhipinti

Reviewer

Giovanni Occhipinti
Daniele Giacoppo

Reviewer

Daniele Giacoppo
PCI vs CABG surgery for LM disease in patients with and without ACS: a pooled analysis of 4 randomized clinical trials

Outcomes of transcatheter aortic valve replacement in patients with cardiogenic shock

03 Jul 2023

This is the largest real world observational data that confirms the safety and efficacy of TAVR for the treatment of patients with severe aortic stenosis presenting with cardiogenic shock. 

Dr. Mirvat Alasnag

Reviewer

Mirvat Alasnag
Hady Lichaa

Reviewer

Hady Lichaa
Outcomes of transcatheter aortic valve replacement in patients with cardiogenic shock

PCI or CABG for left main coronary artery disease: the SWEDEHEART registry

28 Jun 2023

While the choice between PCI and CABG for LMCA disease continues to be one of the most controversial topics, patient characteristics & comorbidities must be taken into account, as must the external validity of the results of RCTs in the real world, as the SWEDEHEART registry does.

Panagiotis Xaplanteris

Reviewer

Panagiotis Xaplanteris

Reviewer

Leonidas Koliastasis
PCI or CABG for left main coronary artery disease: the SWEDEHEART registry

TAVI with the Evolut platform for bicuspid aortic valve stenosis: the international, multicentre, prospective BIVOLUTX registry

22 Jun 2023

The single-arm BIVOLUTX registry provides an accurate picture of contemporary practice and clinical outcomes of TAVI in BAV patients with AS, adding valuable prospective evidence to the field.

Alessandro Beneduce

Reviewer

Alessandro Beneduce

Reviewer

Ali Nazmi Calik
Transcatheter aortic valve implantation with the Evolut platform for bicuspid aortic valve stenosis: the international, multicentre, prospective BIVOLUTX registry

Venoarterial extracorporeal membrane oxygenation or standard care in patients with cardiogenic shock complicating acute myocardial infarction: the multicentre, randomised EURO SHOCK trial

22 May 2023

The EUROSHOCK trial aimed to determine if early use of VA-ECMO could improve outcomes in patients with persistent CS following pPCI.

Elad Asher

Reviewer

Elad Asher
Venoarterial extracorporeal membrane oxygenation or standard care in patients with cardiogenic shock complicating acute myocardial infarction: the multicentre, randomised EURO SHOCK trial

Interventional solutions for post-surgical problems

18 May 2023 – From EuroPCR 2023

Experience the cutting-edge world of interventional solutions for post-surgical problems in this session: delve into intriguing cases like acquired left circumflex stenosis after aortic valve surgery presenting as thin cap fibroatheroma, encounter the rare complication of a giant submitral left ventricle pseudo-aneurysm following mitral valve surgery,...

Interventional solutions for post-surgical problems

Prognostic value of tricuspid valve gradient after transcatheter edge-to-edge repair : insights from the TriValve registry

17 Apr 2023

The present study aimed to address the association between the mean TVG at discharge and outcomes among patients who underwent tricuspid TEER within the TriValve Registry.  

Edoardo Zancanaro

Reviewer

Edoardo Zancanaro
Prognostic value of TVG after TEER: insights from the TriValve registry

Minimally invasive vs conventional sternotomy for mitral valve repair surgery: An expertise based multicentre randomised controlled trial (UK Mini Mitral)

07 Mar 2023

Reported from ACC 2023 / WCC

Edoardo Zancanaro provides his take on this clinical trial presented by Enoch Akowuah at the American College of Cardiology Scientific Session (ACC.23/WCC).

Edoardo Zancanaro

Author

Edoardo Zancanaro
Minimally invasive versus conventional sternotomy for mitral valve repair surgery: An expertise based multicentre randomised controlled trial (UK Mini Mitral)

2-year outcomes of transcatheter mitral valve replacement in patients with annular calcification, rings, and bioprostheses

26 Jan 2023

The aim of this study is to present the TMVR results at 2 years from the MITRAL population.

Edoardo Zancanaro

Reviewer

Edoardo Zancanaro
2-year outcomes of transcatheter mitral valve replacement in patients with annular calcification, rings, and bioprostheses